SCHEMBL30965172

SCHEMBL30965172

CC(=O)Nc1cc2c(cc1OCCOCCN(C)C)C(=O)N(CC(=O)O)C2=O

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
ROCK2 O75116 1/20 0.41
KDM4E B2RXH2 10/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
TDP1 Q9NUW8 3/20 0.37
LMNA P02545 1/20 0.37
LPAR1 Q92633 1/20 0.36
LPAR3 Q9UBY5 1/20 0.36
CHEK1 O14757 1/20 0.35
ATR Q13535 1/20 0.35
CA12 O43570 1/20 0.34
CA9 Q16790 1/20 0.34
BRPF1 P55201 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30965237 0.90 HPGD (0.43) ALDH1A1ROCK2KDM4ESMN1; SMN2ADRB2
SCHEMBL30965216 0.88 KDM4E (0.40) ALDH1A1ROCK2KDM4ESMN1; SMN2ADRB2
SCHEMBL30965227 0.86 ALDH1A1 (0.40) ALDH1A1KDM4ESMN1; SMN2ADRB2ADRB1
SCHEMBL30965251 0.83 ALDH1A1 (0.45) ALDH1A1KDM4ESMN1; SMN2ADRB2ADRB1
SCHEMBL30965268 0.82 ALDH1A1 (0.44) ALDH1A1KDM4ESMN1; SMN2ADRB2ADRB1
SCHEMBL30965202 0.81 TDP1 (0.40) ALDH1A1SMN1; SMN2KMT2AMEN1TDP1
SCHEMBL30965174 0.77 AKR1B1 (0.42) KMT2ATDP1CA12CA9
SCHEMBL30965196 0.76 ALDH1A1 (0.39) ALDH1A1KDM4ESMN1; SMN2ADRB2ADRB1
SCHEMBL30965143 0.75 NAAA (0.38) ALDH1A1KDM4EKMT2AMEN1
SCHEMBL30965233 0.75 KDM4E (0.39) ALDH1A1KDM4ESMN1; SMN2ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118125964-A Isoindoline-1, 3-diketone mPGES-1 inhibitor and application thereof 长江大学 2024-06-04 CN disclosed